SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-17-179568
Filing Date
2017-05-23
Accepted
2017-05-23 16:02:03
Documents
5
Period of Report
2017-05-23

Document Format Files

Seq Description Document Type Size
1 6-K d401391d6k.htm 6-K 11796
2 EX-99.1 d401391dex991.htm EX-99.1 155665
3 EX-99.2 d401391dex992.htm EX-99.2 70580
4 EX-99.3 d401391dex993.htm EX-99.3 60230
5 GRAPHIC g401391g48q73.jpg GRAPHIC 9002
  Complete submission text file 0001193125-17-179568.txt   311683
Mailing Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 17863749
SIC: 2834 Pharmaceutical Preparations